ACSS2 and cancer: To compensate, cancer cells adopt different metabolic mechanisms, such as HIF-dependent stimulation of reductive glutamine metabolism, or acyl-CoA synthetase short-chain family member 2 (ACSS2)-mediated acetate metabolism for alternative sources of FA precursors (76).